Stock abbreviation: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Stock Code: 600521 Announcement No.: Lin 2022-002
Bond abbreviation: Huahai convertible bond bond Code: 110076
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521)
Announcement on the progress of repurchase of shares of the company by means of centralized bidding transaction
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Implementation of repurchase plan: as of December 31, 2021, the company has repurchased 7790608 shares of the company, accounting for 0.5222% of the total share capital of the company. The highest transaction price is 21.055 yuan / share, the lowest price is 16.01 yuan / share, and the total transaction amount is 149991670.6 yuan (excluding stamp duty, transaction commission and other related expenses).
1、 Basic information of repurchase
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) (hereinafter referred to as “the company”) held the second meeting of the seventh board of directors and the 2020 annual general meeting of shareholders on April 23, 2021 and May 18, 2021 respectively. The meeting deliberated and adopted the proposal on repurchase of shares of the company by centralized bidding transaction, It is agreed that the company will use its own funds to repurchase the company’s shares in the form of centralized bidding transaction for the implementation of employee stock ownership plan or equity incentive, and the repurchase amount shall not be less than RMB 100 million (inclusive) and not more than RMB 200 million (inclusive), The repurchase price shall not exceed 24.80 yuan / share (including) (the company originally set the upper limit of the repurchase price at 25 yuan / share. Since the company implemented the 2020 annual profit distribution plan, that is, the company distributed a cash dividend of 0.2 yuan per share (including tax), the company adjusted the upper limit of the repurchase price from 25 yuan / share to 24.80 yuan / share according to the provisions of relevant laws and regulations), The repurchase period is 12 months from the date when the company’s 2020 annual general meeting deliberates and approves the share repurchase plan.
For details, please refer to China Securities Journal, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange on April 26, 2021, May 19, 2021 and June 12, 2021 com.. cn. Announcement of Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) on share repurchase scheme by centralized bidding transaction (p.2021-028), announcement of Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) resolution of 2020 annual general meeting of shareholders (p.2021-040), announcement of Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) on adjusting the upper limit of share repurchase price (p.2021-056).
2、 Progress of repurchase
According to the company law, the detailed rules for the implementation of share repurchase by listed companies of Shanghai Stock Exchange and other relevant provisions, during the repurchase period, the company shall announce the repurchase progress as of the end of last month on the first three trading days of each month. The progress of the company’s share repurchase is hereby announced as follows:
In December 2021, the Company repurchased 2250293 shares through centralized competitive bidding, accounting for 0.1508% of the total share capital of the company. The highest transaction price was 21.00 yuan / share, the lowest price was 19.94 yuan / share, and the total transaction amount was 45990621.02 yuan (excluding stamp duty, Trading Commission and other related expenses).
As of December 31, 2021, the company has bought back 7790608 shares of the company, accounting for 0.5222% of the total share capital of the company. The highest transaction price is 21.055 yuan / share, the lowest price is 16.01 yuan / share, and the total transaction amount is 149991670.6 yuan (excluding stamp duty, transaction Commission and other related expenses).
3、 Other instructions
Subsequently, the company will implement the repurchase plan within the repurchase period in accordance with the requirements of normative documents such as the detailed rules for the implementation of share repurchase by listed companies of Shanghai Stock Exchange and market conditions, and timely perform the obligation of information disclosure in accordance with the requirements of relevant normative documents. Please pay attention to investment risks.
It is hereby announced.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) board of directors
January 3, 2022
